The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis
Open accessAbstract
Chemical modulation of histone deacetylase (HDAC) activity by HDAC inhibitors (HDACi) is an increasingly important approach to modify the etiology of human disease. Loss-of-function diseases arise as a consequence of protein misfolding and degradation leading to system failures. The ΔF508 mutation in cystic fibrosis transmembrane conductance regulator (CFTR) results in the absence of the cell surface chloride channel and a loss of airway hydration, leading to premature lung failure and reduced lifespan responsible for cystic fibrosis (CF). We now show that the HDACi suberoylanilide hydroxamic acid (SAHA) restores surface channel activity in human primary airway epithelia to levels that are 28% of wild-type CFTR. Biological silencing of all known class I and II HDACs reveals that HDAC7 plays a central role in restoration of ΔF508 function. We suggest that the tunable capacity of HDACs can be manipulated by chemical biology to counter the onset of CF and other human misfolding disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Update on Key Emerging Challenges in Cystic Fibrosis
Jennings, M. T., Riekert, K. A., & Boyle, M. P. (2014) · Medical Principles and Practice · doi:10.1159/000357646 · Cited by 3,648
Haberland, M., Montgomery, R. L., & Olson, E. N. (2009) · Nature Reviews Genetics · doi:10.1038/nrg2485 · Cited by 2,526
Adapting Proteostasis for Disease Intervention
Balch, W. E., Morimoto, R. I., Dillin, A., & Kelly, J. W. (2008) · Science · doi:10.1126/science.1141448 · Cited by 2,495
Self-citationÖzcan, U., Yilmaz, E., Özcan, L., Furuhashi, M., Vaillancourt, E., Smith, R. O., Görgün, C. Z., & Hotamisligil, G. S. (2006) · Science · doi:10.1126/science.1128294 · Cited by 2,413
The Sir2 Family of Protein Deacetylases
Blander, G., & Guarente, L. (2004) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.73.011303.073651 · Cited by 1,495
Marks, P. A., & Breslow, R. (2007) · Nature Biotechnology · doi:10.1038/nbt1272 · Cited by 1,196
HDAC6 Regulates Hsp90 Acetylation and Chaperone-Dependent Activation of Glucocorticoid Receptor
Kovacs, J. J., Murphy, P. J. M., Gaillard, S., Zhao, X., Wu, J.-T., Nicchitta, C. V., Yoshida, M., Toft, D. O., Pratt, W. B., & Yao, T.-P. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.04.021 · Cited by 1,153 · cited 1×
“16 ), an HDAC-sensitive chaperone that is inhibited by acetylatio”
BackgroundBiological and Chemical Approaches to Diseases of Proteostasis Deficiency
Powers, E. T., Morimoto, R. I., Dillin, A., Kelly, J. W., & Balch, W. E. (2009) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.052308.114844 · Cited by 1,149
Self-citationStress-inducible regulation of heat shock factor 1 by the deacetylase SIRT1
Westerheide, S. D., Anckar, J., Stevens, S. M., Sistonen, L., & Morimoto, R. I. (2009) · Science · doi:10.1126/science.1165946 · Cited by 639
CFTR Function and Prospects for Therapy
Riordan, J. R. (2008) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.75.103004.142532 · Cited by 610
Self-citationHsp90 Cochaperone Aha1 Downregulation Rescues Misfolding of CFTR in Cystic Fibrosis
Wang, X., Venable, J., LaPointe, P., Hutt, D. M., Koulov, A. V., Coppinger, J., Gurkan, C., Kellner, W., Matteson, J., Plutner, H., et al. (2006) · Cell · doi:10.1016/j.cell.2006.09.043 · Cited by 601
Self-citationUnraveling the hidden catalytic activity of vertebrate class IIa histone deacetylases
Lahm, A., Paolini, C., Pallaoro, M., Nardi, M. C., Jones, P., Neddermann, P., Sambucini, S., Bottomley, M. J., Lo Surdo, P., Carfı́, A., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0706487104 · Cited by 566
Histone Deacetylase 7 Maintains Vascular Integrity by Repressing Matrix Metalloproteinase 10
Chang, S., Young, B. D., Li, S., Qi, X., Richardson, J. A., & Olson, E. N. (2006) · Cell · doi:10.1016/j.cell.2006.05.040 · Cited by 453
Histone deacetylase inhibitors reverse gene silencing in Friedreich's ataxia
Herman, D., Jenssen, K., Burnett, R., Soragni, E., Perlman, S. L., & Gottesfeld, J. M. (2006) · Nature Chemical Biology · doi:10.1038/nchembio815 · Cited by 442 · cited 1×
“The potential benefit of inhibiting HDAC7 in correction of cystic fibrosis disease is supported by the effects of HDAC inhibition on reversing other diseases including those involving transcriptional silencin”
BackgroundSelf-citationNew insights into cystic fibrosis: molecular switches that regulate CFTR
Guggino, W. B., & Stanton, B. A. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1949 · Cited by 432
An Acetylation Site in the Middle Domain of Hsp90 Regulates Chaperone Function
Scroggins, B. T., Robzyk, K., Wang, D., Marcu, M. G., Tsutsumi, S., Beebe, K., Cotter, R. J., Felts, S., Toft, D., Karnitz, L., et al. (2007) · Molecular Cell · doi:10.1016/j.molcel.2006.12.008 · Cited by 413 · cited 1×
“4-phenylbutyrate (4PBA) (10) (Supplemental Fig.”
Lukacs, G. L., Mohamed, A., Kartner, N., Chang, X. B., Riordan, J. R., & Grinstein, S. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06954.x · Cited by 396
Self-citationRubenstein, R. C., Egan, M. E., & Zeitlin, P. L. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119788 · Cited by 389
Evidence for airway surface dehydration as the initiating event in CF airway disease
Boucher, R. C. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2006.01744.x · Cited by 356
RUBENSTEIN, R. C., & ZEITLIN, P. L. (1998) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.157.2.9706088 · Cited by 340
Histone deacetylase inhibitors: discovery and development as anticancer agents
Marks, P. A., & Dokmanovic, M. (2005) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.14.12.1497 · Cited by 318
Lin, H., Hu, C., Chan, H., Liew, Y., Huang, H., Lepescheux, L., Bastianelli, E., Baron, R., Rawadi, G., & Clément‐Lacroix, P. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707165 · Cited by 272
The Sirtuin family: therapeutic targets to treat diseases of aging
Milne, J. C., & Denu, J. M. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.019 · Cited by 271
Pathway Mapping Tools for Analysis of High Content Data
Ekins, S., Nikolsky, Y., Bugrim, A., Kirillov, E., & Nikolskaya, T. (2006) · High Content Screening · doi:10.1385/1-59745-217-3:319 · Cited by 255
Human HDAC7 Histone Deacetylase Activity Is Associated with HDAC3in Vivo
Fischle, W., Dequiedt, F., Fillion, M., Hendzel, M. J., Voelter, W., & Verdin, E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104935200 · Cited by 232 · cited 1×
“Furthermore, we show that by siRNA-mediated silencing of the human lung-enriched HDAC7 (ref”
BackgroundWang, X., Matteson, J., An, Y., Moyer, B., Yoo, J.-S., Bannykh, S., Wilson, I. A., Riordan, J. R., & Balch, W. E. (2004) · The Journal of Cell Biology · doi:10.1083/jcb.200401035 · Cited by 222
Self-citationGentzsch, M., Chang, X.-B., Cui, L., Wu, Y., Ozols, V. V., Choudhury, A., Pagano, R. E., & Riordan, J. R. (2004) · Molecular Biology of the Cell · doi:10.1091/mbc.e04-03-0176 · Cited by 212
Self-citationEpigenetic regulation of airway inflammation
Adcock, I. M., Tsaprouni, L., Bhavsar, P., & Ito, K. (2007) · Current Opinion in Immunology · doi:10.1016/j.coi.2007.07.016 · Cited by 207
Yoo, J.-S., Moyer, B. D., Bannykh, S., Yoo, H.-M., Riordan, J. R., & Balch, W. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110263200 · Cited by 200
Self-citationFailure of cAMP agonists to activate rescued ΔF508 CFTR in CFBE41o–airway epithelial monolayers
Bebok, Z., Collawn, J. F., Wakefield, J., Parker, W., Li, Y., Varga, K., Sorscher, E. J., & Clancy, J. P. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.096669 · Cited by 187
Self-citationButterworth, M. B., Edinger, R. S., Johnson, J. P., & Frizzell, R. A. (2005) · The Journal of General Physiology · doi:10.1085/jgp.200409124 · Cited by 174
Self-citationDevor, D. C., Bridges, R. J., & Pilewski, J. M. (2000) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2000.279.2.c461 · Cited by 170
Self-citationA therapeutic role for sirtuins in diseases of aging?
WESTPHAL, C., DIPP, M., & GUARENTE, L. (2007) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.09.008 · Cited by 168
Bates, E. A., Victor, M., Jones, A. K., Shi, Y., & Hart, A. C. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3344-05.2006 · Cited by 163
Sun, F., Zhang, R., Gong, X., Geng, X., Drain, P. F., & Frizzell, R. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607085200 · Cited by 157
Self-citationAn Adaptable Standard for Protein Export from the Endoplasmic Reticulum
Wiseman, R. L., Powers, E. T., Buxbaum, J. N., Kelly, J. W., & Balch, W. E. (2007) · Cell · doi:10.1016/j.cell.2007.10.025 · Cited by 155
Self-citationQu, B.-H., Strickland, E., & Thomas, P. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15739 · Cited by 139
Self-citationAmaral, M. D. (2005) · Pediatric Pulmonology · doi:10.1002/ppul.20168 · Cited by 127
Myerburg, M. M., Butterworth, M. B., McKenna, E. E., Peters, K. W., Frizzell, R. A., Kleyman, T. R., & Pilewski, J. M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m606449200 · Cited by 109
Self-citationHistone deacetylase inhibitors selectively suppress expression of HDAC7
Dokmanovic, M., Perez, G., Xu, W., Ngo, L., Clarke, C., Parmigiani, R. B., & Marks, P. A. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0251 · Cited by 106
The proteostasis boundary in misfolding diseases of membrane traffic
Hutt, D. M., Powers, E. T., & Balch, W. E. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.07.014 · Cited by 98
Self-citationChemical and Biological Folding Contribute to Temperature‐Sensitive ΔF508 CFTR Trafficking
Wang, X., Koulov, A. V., Kellner, W. A., Riordan, J. R., & Balch, W. E. (2008) · Traffic · doi:10.1111/j.1600-0854.2008.00806.x · Cited by 91
Self-citationProtein misfolding disorders: Pathogenesis and intervention
Gregersen, N. V. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0301-4 · Cited by 83
Kasler, H. G., & Verdin, E. M. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02091-06 · Cited by 76
The therapeutic uses of chromatin-modifying agents
Mai, A. (2007) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.11.6.835 · Cited by 61
Pharmacoproteomics of 4-Phenylbutyrate-Treated IB3-1 Cystic Fibrosis Bronchial Epithelial Cells
Singh, O. V., Vij, N., Mogayzel, P. J., Cathy, J., Pollard, H. B., & Zeitlin, P. L. (2006) · Journal of Proteome Research · doi:10.1021/pr050319o · Cited by 61
Lei, D., Kunzelmann, K., Koslowsky, T. C., Yezzi, M. J., Escobar, L. C., Xu, Z., Ellison, A. R., Rommens, J. M., Lc, T., Tykocinski, M. L., et al. (1996) · PubMed · Cited by 56
Mai, A., Jelicic, K., Rotili, D., Noia, A. D., Alfani, E., Valente, S., Altucci, L., Nebbioso, A., Massa, S., Galanello, R., et al. (2007) · Molecular Pharmacology · doi:10.1124/mol.107.036772 · Cited by 35
Cited by
Correction of the F508del-CFTR protein processing defect in vitro by the investigational drug VX-809
Van Goor, F., Hadida, S., Grootenhuis, P. D. J., Burton, B., Stack, J. H., Straley, K. S., Decker, C. J., Miller, M., McCartney, J., Olson, E. R., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1105787108 · Cited by 1,088
Self-citationVeit, G., Avramescu, R. G., Chiang, A. N., Houck, S. A., Cai, Z., Peters, K. W., Hong, J. S., Pollard, H. B., Guggino, W. B., Balch, W. E., et al. (2016) · Molecular Biology of the Cell · doi:10.1091/mbc.e14-04-0935 · Cited by 580
Self-citationmTORC1 activation in podocytes is a critical step in the development of diabetic nephropathy in mice
Inoki, K., Mori, H., Wang, J., Suzuki, T., Hong, S., Yoshida, S., Blattner, S. M., Ikenoue, T., Rüegg, M. A., Hall, M. N., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44771 · Cited by 538
CFTR Modulators: The Changing Face of Cystic Fibrosis in the Era of Precision Medicine
Lopes-Pacheco, M. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2019.01662 · Cited by 535
Progress in therapies for cystic fibrosis
De Boeck, K., & Amaral, M. D. (2016) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(16)00023-0 · Cited by 451
Metadata
- Authors
- Hutt, D. M., Herman, D., Rodrigues, A. P. C., Noel, S., Pilewski, J. M., Matteson, J., Hoch, B., Kellner, W., Kelly, J. W., Schmidt, A., Thomas, P. J., Matsumura, Y., Skach, W. R., Gentzsch, M., Riordan, J. R., Sorscher, E. J., Okiyoneda, T., Yates, J. R., Lukacs, G. L., Frizzell, R. A., Manning, G., Gottesfeld, J. M., & Balch, W. E.
- Venue
- Nature Chemical Biology
- Published
- 2009-12-06
- Volume
- 6
- Issue
- 1
- Pages
- 25-33
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- OpenAlex
- W2125639616
- Cited by
- 252
- References
- 48
- FWCI
- 18.04
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.